EGFL7 and gastric cancer: It has been reported that gastric cancer (GC) cells (Luo et al., 2014), liver cancer (HCC) cells (Shen et al., 2016), and pituitary adenocarcinoma cells (Wang et al., 2017) have considerably improved migration and invasion capabilities because of the overexpression of EGFL7.